Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures
Condition(s) studied
Investigational drug(s) / intervention(s)
Volta tAN System: Transcutaneous auricular neurostimulation (tAN)
SHAM Volta tAN System: Participants randomized to the sham group will have an earpiece applied, but stimulation will not be turned on.
Study summary
The objective of this study is to determine if tAN therapy can reduce the volume of blood lost during dialysis AV graft placement procedures.
Eligibility
Primary outcome measure(s)
- Mean Total Blood Loss — Throughout procedure
Comparison of mean total quantified blood loss in active tAN versus sham tAN groups.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| University Surgical Vascular | Watkinsville | Georgia | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06647017 on ClinicalTrials.gov ↗ ← All trials in the USA